Literature DB >> 2850054

Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord.

Y Kudo1, E Akiyoshi, H Akagi.   

Abstract

1. Effects of taurine on primary afferent terminals in the frog spinal cord were examined by a sucrose-gap method applied to a dorsal root (9th or 10th segment). 2. In a normal Ringer solution, taurine (1 mM, applied for 5s at a rate of 0.04 ml s-1, 0.2 mumol) caused a hyperpolarization, but a higher concentration (10 mM, applied at the same rate, 2.0 mumol) caused a biphasic response consisting of a hyperpolarization followed by a slow onset depolarization. A similar biphasic response could also be observed in tetrodotoxin-treated preparations. 3. When the concentration of extracellular Mg2+ was increased up to 9.0 mM, the depolarizing response to taurine was augmented. The rate of the augmentation was dependent upon the extracellular Mg2+ concentration. 4. The depolarizing effect was selectively antagonized by bicuculline in concentrations (10-30 microM) that had no significant antagonizing action on gamma-aminobutyric acid (GABA)-induced depolarization. On the other hand the hyperpolarizing effect of taurine was selectively reduced by strychnine (0.1 microM) which had no antagonizing effect on responses to glycine. 5. These results suggest that in the frog spinal cord there are at least two subtypes of taurine receptor whose pharmacological profiles resemble GABA and glycine receptors in the mammalian central nervous system, and whose sensitivity may be modulated by extracellular Mg2+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850054      PMCID: PMC1854083          DOI: 10.1111/j.1476-5381.1988.tb11621.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Bimodal action of glycine on frog spinal motoneurones.

Authors:  R H Evans; A A Francis; J C Watkins
Journal:  Brain Res       Date:  1976-12-24       Impact factor: 3.252

2.  Analysis of amino acid responses on frog motoneurones.

Authors:  R A Nicoll; A Padjen; J L Barker
Journal:  Neuropharmacology       Date:  1976-01       Impact factor: 5.250

3.  Studies on convulsants in the isolated frog spinal cord. II. Effects on root potentials.

Authors:  J L Barker; R A Nicoll; A Padjen
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

4.  The action of taurine on the lobster muscle fibre an d the frog spinal cord.

Authors:  A Nistri; A Constanti
Journal:  Neuropharmacology       Date:  1976-10       Impact factor: 5.250

5.  Antagonism between bicuculline and GABA in the cat brain.

Authors:  D R Curtis; A W Duggan; D Felix; G A Johnston; H McLennan
Journal:  Brain Res       Date:  1971-10-08       Impact factor: 3.252

6.  Factors affecting the release of (14C)taurine from cat brain: the electrical effects of taurine on normal and seizure prone cortex.

Authors:  L K Kaczmarek; W R Adey
Journal:  Brain Res       Date:  1974-08-09       Impact factor: 3.252

7.  Central actions of shikimin and tutin.

Authors:  D R Curtis; J Davies; C J Game; G A Johnston; R M McCulloch
Journal:  Brain Res       Date:  1973-12-07       Impact factor: 3.252

8.  The chloride-dependent depression by GABA in the frog spinal cord.

Authors:  Y Kudo; N Abe; S Goto; H Fukuda
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

9.  Magnesium gates glutamate-activated channels in mouse central neurones.

Authors:  L Nowak; P Bregestovski; P Ascher; A Herbet; A Prochiantz
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

10.  Studies on convulsants in the isolated frog spinal cord. I. Antagonism of amino acid responses.

Authors:  J L Barker; R A Nicoll; A Padjen
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

View more
  5 in total

1.  Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation.

Authors:  N Hussy; C Deleuze; A Pantaloni; M G Desarménien; F Moos
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

Review 2.  Taurine and the Brain.

Authors:  Simon S Oja; Pirjo Saransaari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Review: taurine: a "very essential" amino acid.

Authors:  Harris Ripps; Wen Shen
Journal:  Mol Vis       Date:  2012-11-12       Impact factor: 2.367

4.  Neuroprotective Mechanisms of Taurine against Ischemic Stroke.

Authors:  Janet Menzie; Howard Prentice; Jang-Yen Wu
Journal:  Brain Sci       Date:  2013-06-03

Review 5.  Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship.

Authors:  Sofía Ramírez-Guerrero; Santiago Guardo-Maya; Germán J Medina-Rincón; Eduardo E Orrego-González; Ricardo Cabezas-Pérez; Rodrigo E González-Reyes
Journal:  Front Mol Neurosci       Date:  2022-07-05       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.